Enzo Biochem (ENZ) Reports In-Line Q1 Loss
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Price: $0.31 --0%
Financial Fact:
Selling, general, and administrative: 11.47M
Today's EPS Names:
MAYS, CRMT, REPL, More
Financial Fact:
Selling, general, and administrative: 11.47M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Enzo Biochem (NYSE: ENZ) reported Q1 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $25.2 million versus the consensus estimate of $25 million.
For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
